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We present the case of a 56-year-old male with a history of recurrent follicular lymphoma
undergoing chemotherapy with multiple 18F-FDG PET-CT studies at an outside facility. He
developed a painful erythematous, pruritic rash in the left back requiring a visit to the
emergency room. He was diagnosed and treated for Varicella zoster infection. He then
presented to our imaging center 2 months later for a follow up 18F-FDG PET/CT study.
Imaging demonstrated a cutaneous band of increased metabolic activity in the upper back
following a dermatomal distribution. This was confirmed to be in the same area as the
treated Varicella zoster eruption. A subsequent follow up 18F-FDG PET-CT scan 4 months
later to confirm tumor resolution demonstrated the abnormal band of uptake in the back
had resolved. This case illustrates the significance of being aware of this entity and to
distinguish it from metastasis, especially in patients with a known history of malignancy.
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CASE PRESENTATION
A 56-year-old male with a history of stage IIIA follicular lym-
phoma initially diagnosed 2 years prior to arriving at our imag-
ing facility as a follow up to treatment. He was initially treated
with an R-CVP (Rituximab, Cyclophosphamide, Vincristine, and
Prednisone) chemotherapy regimen and attributed a complete
response. However, he had evidence of relapse a year later. He was
then placed on a MOPP-R regimen (Mustargen, Oncovin, Procar-
bazine, Prednisone, and Rituximab) and had multiple 18F-FDG
PET-CT studies at an outside facility. The most recent PET-CT
from 6 months earlier showed no evidence of malignancy. Since
the patient had a history of recurrence, a repeat PET-CT scan to
document stability was performed at our facility which demon-
strated a superficial band of increased metabolic activity in the
left mid back following a dermatomal distribution and associated
mild skin thickening (see Figure 1). The managing oncologist
informed us that the patient had gone to the emergency room
2 months prior to the PET-CT. He presented there with a painful
erythematous, pruritic rash in the left mid back following the
T10-12 dermatome. The emergency room physician diagnosed
the patient with Varicella zoster and treated him with pain med-
ication and valacyclovir 1000 mg orally three times per day for
7 days.
Two weeks after the emergency room visit, he returned to his
oncologist for a follow up appointment and physical examination
found crusted lesions in the area of the rash. The patient contin-
ued to have neuropathic pain in the area and was taking oxycodone
for relief. He had been prescribed valacyclovir 500 mg orally twice
daily as prophylaxis prior to the outbreak,but he admit to not being
adherent. The patient returned to our imaging facility 4 months
after the previous PET-CT and the superficial band of increased
metabolic activity in the left mid back had resolved. A month later
the patient returned to his oncologist with no signs of a rash.
FIGURE 1 | 18FDG PET images demonstrating a dermatomal
distribution of increased metabolic activity in the left upper back
(arrows).These findings were consistent with active Varicella zoster
infection clinically.
DISCUSSION
Varicella zoster is a common but serious infection in immunocom-
promised patients, especially in those with deficient cell-mediated
immunity. However, it is often effectively prophylaxed with antivi-
rals in these patients. The infection typically manifests as a painful
rash often limited to a skin dermatome but can spread caus-
ing more serious complications and become life threatening.
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Active infection will show increased metabolic activity in the
inflammatory cells on FDG PET images.
ActiveVaricella zoster infection is not routinely seen on PET-CT
in our experience. There are only a few case reports describing this
uncommon entity (Joyce and Carlos, 2006; Nair and Al Shemmari,
2011). However, none of these cases demonstrate a dermatomal
distribution, as seen in our case, which may help in differentiating
it from cutaneous metastasis. Valacyclovir is commonly used in
the treatment of infection in immunocompromised patients and
has been found to reduce the incidence of herpesviridae infection
(Anderson et al., 1984; Lee et al., 2012).
CONCLUSION
Active infection with Varicella zoster virus may display increased
metabolic activity in the inflammatory cells on PET. This case
illustrates the significance of being aware of this entity and to
distinguish it from metastasis, especially in patients with known
malignancy (Castellucci et al., 2005).
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